Cargando…

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?

A rising incidence of thyroid cancers (TCs) mainly small tumors, observed during recent years, lead to many controversies regarding treatment strategies. TCs represent a distinct molecular background and clinical outcome. Although in most cases TCs are characterized by a good prognosis, there are so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rusinek, Dagmara, Chmielik, Ewa, Krajewska, Jolanta, Jarzab, Michal, Oczko-Wojciechowska, Malgorzata, Czarniecka, Agnieszka, Jarzab, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578203/ https://www.ncbi.nlm.nih.gov/pubmed/28829399 http://dx.doi.org/10.3390/ijms18081817

Ejemplares similares

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors
por: Czarniecka, Agnieszka, et al.
Publicado: (2015)

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Novel TG‐FGFR1 and TRIM33‐NTRK1 transcript fusions in papillary thyroid carcinoma
por: Pfeifer, Aleksandra, et al.
Publicado: (2019)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma – Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015
por: Czarniecka, Agnieszka, et al.
Publicado: (2021)

Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of (1)H HR MAS NMR spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
por: Szpak-Ulczok, Sylwia, et al.
Publicado: (2020)

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2015)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
por: Rusinek, Dagmara, et al.
Publicado: (2018)

Gene signature of the post-Chernobyl papillary thyroid cancer
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2016)

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
por: Pfeifer, Aleksandra, et al.
Publicado: (2013)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision
por: Czarniecka, Agnieszka, et al.
Publicado: (2010)

Lobo-isthmectomy in the management of differentiated thyroid cancer
por: Krajewska, Jolanta, et al.
Publicado: (2023)

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
por: Krajewska, Jolanta, et al.
Publicado: (2020)

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
por: Krajewska, Jolanta, et al.
Publicado: (2019)

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
por: Fujarewicz, Krzysztof, et al.
Publicado: (2007)

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
por: Jarzab, Barbara, et al.
Publicado: (2013)

Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features
por: Zakrzewski, Krzysztof, et al.
Publicado: (2015)

Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal
por: Chechlinska, Magdalena, et al.
Publicado: (2009)

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages
por: Warakomski, Jakub, et al.
Publicado: (2018)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

Comparison of clinical examination with orbital MRI evaluation in patients with thyroid orbitopathy - do we need imaging and when?
por: Król, Aleksandra, et al.
Publicado: (2013)

Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes
por: Kowalewska, Magdalena, et al.
Publicado: (2012)

A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas
por: Dom, G, et al.
Publicado: (2012)

Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies
por: Daca-Roszak, Patrycja, et al.
Publicado: (2015)

Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells
por: Di Maro, Gennaro, et al.
Publicado: (2014)

A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
por: Soczomski, Przemysław, et al.
Publicado: (2021)

Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
por: Dudaladava, Volha, et al.
Publicado: (2006)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020)

Treatment of advanced thyroid cancer refractory to therapy
por: Jarząb, Barbara
Publicado: (2013)

Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer
por: Kukulska, Aleksandra, et al.
Publicado: (2021)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
por: Krajewska, Jolanta, et al.
Publicado: (2013)

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma
por: Kukulska, Aleksandra, et al.
Publicado: (2019)

Are We Ready for the Rising Silent Epidemic of Metabolic Syndrome and Chronic Non-Communicable Disease in Ethiopia?
por: Belachew, Tefera
Publicado: (2015)

Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”
por: Jarzab, Barbara, et al.
Publicado: (2013)

Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma
por: Gaweł, Agata M., et al.
Publicado: (2021)

Transcriptomic population markers for human population discrimination
por: Daca-Roszak, P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m9egn7ibqh1ukjfd8mg2rsqufo